Chronic Migraine Botox

FDA‑Approved Treatment for Chronic Migraine

Botox is an FDA‑approved preventive treatment for chronic migraine, defined clinically as 15 or more headache days per month for at least three months, with at least eight days meeting criteria for migraine. Treatment is performed every 12 weeks using established protocols that target pain pathways involving peripheral nerve signaling and muscle activation.

Bare Face RVA provides physician‑led migraine Botox care in a focused, boutique medical setting — combining clinical precision with continuity of care.